Hyzaar: A Comprehensive Overview of the Losartan-Hydrochlorothiazide Combination
-
BY Dell Dibella
- July 24, 2026 12:07 pm
- no comment
Hyzaar is a fixed-dose combination medication containing losartan potassium, an angiotensin II receptor blocker (ARB), and hydrochlorothiazide (HCTZ), a thiazide diuretic. Approved by the U.S. Food and Drug Administration (FDA) in 1995, it is primarily indicated for the treatment of hypertension to lower blood pressure and reduce the risk of stroke and cardiovascular events. This […]